Search Results
Displaying 1 - 41 of 41
The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and therapeutics.
… Vaccines Governance & Leadership Overview Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) is a … and speeding development of the most promising COVID-19 vaccines and treatments. ACTIV brings together NIH …
… on best practices for the use of small animal models for COVID 19 research. The videos were developed in an effort to … models. This effort has been led by the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) …
… a Medical Condition (including Those at High Risk for COVID-19) COVID-19 Leave Employee Benefits - Benefits Contacts Employee …
North Bethesda, MD, April 8, 2020 –The Foundation for the National Institutes of Health (FNIH) has established a Pandemic Response Fund to support the National Institutes of Health (NIH), led by Francis S. Collins, M.D., Ph.D., and NIH’s National Institute for Allergy and Infectious Diseases (NIAID), led by Anthony S. Fauci, M.D., in their efforts to rapidly end the threat from COVID-19.
… Pandemic Response Fund to Support NIH and NIAID in COVID-19 Efforts April 8, 2020 North Bethesda, MD, April 8, 2020 … M.D., in their efforts to rapidly end the threat from COVID-19. Contributions to the fund will enable the NIH to …
Health agencies, leading pharmaceutical companies to join forces to accelerate pandemic response
… NIH to Launch Public-Private Partnership to Speed COVID-19 Vaccine and Treatment Options April 17, 2020 Health … strategy for a coordinated research response to the COVID-19 pandemic. The planned Accelerating COVID-19 …
… M.D., in their efforts to rapidly end the threat from COVID-19. Gifts will be used to support NIH’s efforts to accelerate … research on potential treatments and vaccines for COVID-19 and to prepare the United States to defend against …
… Seminar Series: Post-Acute Sequelae of SARS-CoV-2 Overview COVID patients who experience lingering symptoms for months … to have post-acute sequelae of SARS-CoV-2 (PASC), or long COVID. Major gaps in our understanding of the preclinical and … therapeutic interventions. The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership …
//-->
… and NIAID in their efforts to rapidly end the threat from COVID-19 and to prepare the United States to defend against future … NIH and FNIH to Launch Partnership to Speed COVID-19 Vaccine and Treatment Options This partnership will …
The Foundation for the National Institutes of Health (FNIH) is honored to announce Anthony S. Fauci, M.D., as the recipient of the 2020 Charles A. Sanders, M.D., Partnership Award.
… research in lethal infectious diseases, most recently for Covid-19. “Dr. Fauci has long been considered a national treasure … to combat infectious diseases, including the current Covid-19 pandemic.” As NIAID Director since 1984, Dr. Fauci …
… National Institutes of Health's (NIH’s) efforts to speed COVID-19 vaccine and treatment research and prepare the United … accelerate development of vaccines and therapies to combat COVID-19, the greatest public health challenge of our time. …
… in Cancer Research Tackling Alzheimer’s Disease Combating COVID-19 and More Advancing Research Driving Breakthroughs in Cancer Research Tackling Alzheimer’s Disease Combating COVID-19 and More Advancing Research Help the FNIH marshal …
… for the Community Engagement Alliance (CEAL) Against COVID-19 Disparities initiative, a NIH-wide effort led by the … racial/ethnic minority and underserved communities about COVID-19, clinical trials, vaccines and science in general. …
… Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Select Sub …
The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and treatments.
… a single control arm to enhance trial efficiency COMBAT COVID Learn more about which trials you might be eligible … who are not hospitalized - Adults who have been exposed to COVID-19 but have not developed the disease - Adult hospitalized …
… of unexplained fever, influenza, Ebola and of late, COVID-19. Dr. Lane has partnered with host country governments to … HIV Infection and the NIH Treatment Guidelines Panel for COVID-19. He serves on the Strategic and Technical Advisory …
The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and treatments.
… immune response Resources Prospects for a safe COVID-19 vaccine …
… to develop treatments and diagnostics to address the COVID-19 pandemic. Discovery and innovation must keep pace with … . Communicable Diseases As of January 1, 2021, the COVID-19 pandemic had infected more than 72 million people …
… responsive approach to partnerships than the Accelerating COVID-19 Therapeutic Interventions and Vaccines ( ACTIV ), the … partnership formed to address the unprecedented COVID-19 pandemic. The ACTIV partnership includes eight …
… 10th Annual 2022 FNIH Awards Ceremony , held on October 19, 2022, the Foundation for the National Institutes of … LLC, and to the eight Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) … In support of finding therapeutics and vaccines to combat COVID-19, the Working Group Co-Chairs spent countless hours …
FNIH Board to Launch National Search for Replacement
… critical partnerships, most recently in the fight against COVID-19. She will be greatly missed." During Dr. Freire’s tenure, … (AMP®) and the critically important Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) …
… Vaccines Governance & Leadership Overview The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership …
… the NIH, including our work through the Accelerating COVID-19 Therapeutic Interventions and Vaccines program ( ACTIV ).” …
Dr. Francis S. Collins announced today that he has decided to step down from his role as Director of the National Institutes of Health by the end of this year.
… Medicines Partnership® (AMP®) and Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV). We look …
The FNIH Celebrates 25 Years of Science Leading the Way
… FNIH’s NEW PODCAST Pull Up a Chair with Dr. Freire: The COVID Conversations Listen Now! OUR PROMISE We support the … co-hosted with National Geographic—The Quiet Leaders of COVID: Shaping the Future of Science was held on July 22nd. … To address the most pressing questions regarding the COVID-19 crisis, we initiated a podcast series in which our …
… out of every four people globally is infected with TB. The COVID-19 pandemic has caused major disruptions to the global TB …
The Foundation for the National Institutes of Health (FNIH) will honor Janssen Research & Development, LLC, and the eight Working Group Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative
… and the eight Working Group Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative … In support of finding therapeutics and vaccines to combat COVID-19, the Working Group Co-Chairs spent countless hours …
The Foundation for the Institutes of Health (FNIH) has launched the Deeda Blair Research Initiative for Disorders of the Brain to drive innovation in mental health research.
… health response to, and recovery from, the unprecedented COVID-19 pandemic,” said Mrs. Blair. Learn more about the Deeda …
… vaccine candidate against coronavirus disease 2019 (Covid-19). The vaccine was issued the first emergency use …
… The 10th annual FNIH Awards Ceremony was held October 19, 2022, celebrating scientific excellence and partnership. … LLC, and the eight Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Working …
Developing new drug regimens to transform the care of patients with tuberculosis
… and one of the leading causes of death worldwide. The COVID-19 pandemic has significantly disrupted the global TB … 20, 2020): With tuberculosis resurgent after two years of COVID-19-inspired neglect, TB Alliance is awarded USAID …
The FNIH manages several prestigious prizes recognizing exceptional scientific achievement – motivating researchers, elevating important discoveries into the broader public’s awareness and inspiring the next generation to pursue careers in biomedical research.
Noted donors established these prizes to enrich both the important contributions to the scientific community and the mission of the FNIH. Below are just a few examples of these important initiatives.
… co-hosted with National Geographic—The Quiet Leaders of COVID: Shaping the Future of Science was held on July 22nd. … to the eight Working Group Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative …
… Award at its 10th Annual Awards Ceremony on October 19, 2022. Read More September 27, 2022 The FNIH Announces New … and the eight Working Group Co-Chairs of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative …
The Foundation for the National Institutes of Health (FNIH) will honor Amgen and Dr. Francis Collins as recipients of the 2022 Charles A. Sanders, M.D., Partnership Award at its 10th Annual Awards Ceremony on October 19, 2022.
… Award at its 10th Annual Awards Ceremony on October 19, 2022. This Award recognizes persons and/or organizations … to stem the national opioid crisis. ACTIV (Accelerating Covid-19 Therapeutic Interventions and Vaccines) met its goal … safe and effective therapeutics and vaccines for Covid patients. Over many years, Amgen’s partnership with …
… major research collaborations including the Accelerating COVID - 19 Therapeutic Interventions and Vaccines ( ACTIV ), …
Providing actionable information to assist in monitoring and testing COVID-19 variants
… Sciences, NIH Ryan Connor, Ph.D. Product Owner, COVID-19 SRA Cloud Analysis Tools, SME Viral Genomes, National … Ph.D., M.P.H. Senior Director, Lead Epidemiologist, COVID-19 Vaccines Moderna AJ Venkatakrishnan. Ph.D. Vice …
… process. We are making progress even in the times of the Covid-19 pandemic and look forward to successfully completing the …
Exploring opportunities to put holistic, evidence-based science into practice, shape regulatory and payer interactions, patient and human engagement, product development and embed digital measures into health care decision-making.
… Lajagbe@fnih.org Workshops On February 18 and 19, 2020, the Foundation for the National Institutes of … digital monitoring in clinical trials in the time of COVID-19. Goldsack JC, Izmailova ES, Menetski JP, Hoffmann SC, …
The FNIH and the O’Neill Institute convened high-level meetings to inform the World Health Organization (WHO) and global community on a treaty or other instrument on pandemic preparedness.
… FNIH-O’Neill High Level Meeting on September 8, 2021. The COVID-19 pandemic has resulted in a catastrophic collapse of global …
… neutralizing nanobodies that have potential to prevent COVID-19 mortality when vaccines are compromised. Currently, Dr. Xu …
… a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation Fan Zhang, …
Ann Lurie Discusses Her Stance on Philanthropy, Role in Establishing the Lurie Prize, and Hopes for the Prize Advancing Solutions in Basic Science
… the FNIH Awards Ceremony, planned for the evening October 19, 2022. In addition to celebrating the 10th anniversary of … contributed to the development of the mRNA vaccines for Covid 19. By the way, my husband and I participated in the … health and our experience(s) when we were infected with COVID this year. FNIH: As the Lurie Prize enters its 10th …